Novartis — Spot On West Virginia

WVNews | Business

Global Ophthalmology Drugs Market Report 2019 with Profiles of Novartis, F. Hoffmann-La Roche, Allergan, Valeant Pharmaceuticals, Bayer - ResearchAndMarkets.com

West Virginia Business • Jul 26, 2019

WVNews | Business

Global Respiratory Diseases Drugs Market Report 2019 with Profiles of GlaxosmithKline, AstraZeneca, Merck & Co, Novartis, Johnson & Johnson - ResearchAndMarkets.com

West Virginia Business • Jul 26, 2019

WVNews | Business

Global Cardiovascular Drugs Markets, 2014-2018 & 2019-2022 Featuring Merck & Co, Sanofi, Pfizer, Bristol-Myers Squibb Co, Novartis - ResearchAndMarkets.com

West Virginia Business • Jul 24, 2019

WVNews | Business

Arzerra (ofatumumab; Genmab/Novartis) Drug Overview 2019 - ResearchAndMarkets.com

West Virginia Business • Jul 12, 2019

WVNews | Business

Capmatinib (Incyte/Novartis): Global Drug Overview with Sales for Non-Small Cell Lung Cancer (NSCLC) by Country 2017-2026 - ResearchAndMarkets.com

West Virginia Business • Jul 5, 2019

WVNews | Business

Zykadia (Ceritinib; Novartis) Drug Report 2017-2026 - ResearchAndMarkets.com

West Virginia Business • Jul 4, 2019

WVNews | Business

2019 Trends in Pharma-Patient Engagement, Featuring Bayer HealthCare, GlaxoSmithKline, Johnson-Johnson, Novartis, Novo Nordisk, and Roche - ResearchAndMarkets.com

West Virginia Business • Jul 3, 2019

WVNews | Business

Takeda Completes Sale of Xiidra to Novartis

West Virginia Business • Jul 1, 2019

WVNews | Business

Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecasts, 2019-2023: Led by Amgen, AstraZeneca, Eli Lilly & Co, Roche, and Novartis - ResearchAndMarkets.com

West Virginia Business • Jul 1, 2019

WVNews | Business

Worldwide Generic Injectables Market Outlook 2019-2024 - Dominated by Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi, and Baxter - ResearchAndMarkets.com

West Virginia Business • Jun 28, 2019

WVNews | Business

Global Therapeutic Vaccines Market Overview & Outlook 2019-2023 - Key Players are Aimmune Therapeutics, Immune Response BioPharma, Inovio Pharmaceuticals, Novartis,...

West Virginia Business • Jun 28, 2019

WVNews | Business

PeptiDream Announces New Peptide Drug Conjugate ("PDC") Collaboration Agreement with Novartis

West Virginia Business • Jun 28, 2019

WVNews | Business

Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits, 2018 Report - ResearchAndMarkets.com

West Virginia Business • Jun 27, 2019

WVNews | Business

Farydak (Novartis): Global Drug Report 2017-2026 - ResearchAndMarkets.com

West Virginia Business • Jun 27, 2019

WVNews | Business

Luxturna Approved In EU: Novartis Outlines Lessons For Gene Therapy Strategies - ResearchAndMarkets.com

West Virginia Business • Jun 26, 2019

WVNews | Business

Kymriah (tisagenlecleucel; Novartis) Overview 2019 - ResearchAndMarkets.com

West Virginia Business • Jun 26, 2019

WVNews | Business

Asia-Pacific Over the Counter (OTC) Drugs Market Report 2019-2024 with Key Player Profiles on Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, and Pfizer - ResearchAndMarkets.com

West Virginia Business • Jun 25, 2019

WVNews | Business

Global Surgical Eye Care Market Size, Trends, and Forecasts (2019-2023): Dominated by Novartis, Carl Zeiss Stiftung, Johnson & Johnson, and Bausch Health Companies...

West Virginia Business • Jun 21, 2019

WVNews | Business

Global Sarcoma Market Spotlight 2018-2027: Merck & Co Leads Industry Sponsors with the Highest Number of Overall Clinical Trials for Sarcoma, Followed by Novartis...

West Virginia Business • Jun 20, 2019

WVNews | Business

Global Basal Cell Carcinoma Market Spotlight Report 2019 Featuring Sun Pharmaceutical, Novartis, Roche, & Valeant Pharmaceuticals - ResearchAndMarkets.com

West Virginia Business • Jun 19, 2019

WVNews | Business

Myelofibrosis Market Spotlight 2017-2026: Novartis Leads Industry sponsors with the Highest Number of Clinical Trials, Followed by Incyte - ResearchAndMarkets.com

West Virginia Business • Jun 18, 2019

WVNews | Business

Analysis on the Global Hormone Replacement Therapy Market 2019-2024 - Abbott, Bayer, Merck, Novartis, and Pfizer Hold the Largest Shares - ResearchAndMarkets.com

West Virginia Business • Jun 18, 2019

WVNews | Business

World Heart Failure Drugs Market to Witness a CAGR of 9.1% During 2019-2025 - Dominated by Novartis, GlaxoSmithKline, AstraZeneca, Bayer, and Pfizer - ResearchAndMarkets.com

West Virginia Business • May 30, 2019

WVNews | Business

Global Eye Allergy Therapeutics Market Report 2019-2023 Featuring Akorn, Allergan, Bausch Health Companies, Novartis, & Santen Pharmaceutical - ResearchAndMarkets.com

West Virginia Business • May 28, 2019